Patricia B. Mirasol
InterVenn BioSciences recently raised US$34 million for the commercialization of a minimally invasive blood test for the early detection of ovarian cancer. The San Francisco-based healthtech company innovating on early cancer detection was co-founded by Filipino Aldo Carrascoso (pictured). Image via InterVenn BioSciences
InterVenn Biosciences, a San Francisco-based healthtech company innovating on early cancer detection, was co-founded by Filipino Aldo Carrascoso, who previously founded digital media platform Jukin Media and blockchain payment system Veem.
InterVenn recently raised US$34 million in Series B funding, led by Anzu Partners and participated in by Genoa Ventures, Amplify Partners, True Ventures, Xeraya Capital, and the Ojjeh family (of McLaren Group fame).